vaccines

News

FDA chooses flu vaccine strains despite cancelled meeting

The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season – without the input of its external advisors.

News

Vaccine sector on edge as HHS cancels flu meeting

An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled.

R&D

Ryan Spencer at JP Morgan week 25 interview with Jonah Comstock

JP Morgan Week 2025 – Ryan Spencer

Join CEO Ryan Spencer of Dynavax Technologies in a video interview discussing JP Morgan Week 2025

News

Kennedy delays first vaccine expert meeting under his watch

Less than a week into the tenure of Robert F Kennedy Jr as HHS secretary, there are more signals that US immunisation is going to be shaken up.

News

RFK 'willing to be wrong' on vaccines, but a probe is coming

In his maiden speech as HHS Secretary, RFK Jr said he will investigate the role of childhood vaccines and other 'taboo' topics in chronic disease.

News

Vaccines production line at GSK facility in Wavre, Belgium

GSK gets ready for its next big vaccine launch

GSK joins arch-rival Pfizer in the market for five-in-one meningococcal vaccines with FDA approval for Penmenvy, a top launch prospect for 2025.

FDA chooses flu vaccine strains despite cancelled meeting

Vaccine sector on edge as HHS cancels flu meeting

JP Morgan Week 2025 – Ryan Spencer

Kennedy delays first vaccine expert meeting under his watch

RFK 'willing to be wrong' on vaccines, but a probe is coming

GSK gets ready for its next big vaccine launch

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

vaccines

Editor's Picks